Navigation Links
Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
Date:1/27/2011

basis$
.28$
.24$
.23$
.86 Three Months Ended Twelve Months Ended January 1, 2011January 2, 2010January 1, 2011January 2, 2010Shares used to compute diluted net income from continuing operations per share reconciliationShares used in calculation of diluted net income per share --GAAP59,29857,75059,07157,322Convertible debt dilution impact (1)7,1717,2907,1947,290Weighted average unvested restricted stock awards (2)268624357705Shares used in calculation of diluted net income from continuing operations per share -- non-GAAP66,73765,66466,62265,317(1) The company's total diluted share count on a non-GAAP basis for the three and twelve months ended January 1, 2011 included approximately 7.2 million shares underlying its convertible notes as they were dilutive for the respective periods. The company's total diluted share count on a non-GAAP basis for the three andtwelve months ended January 2, 2010 included approximately 7.3 million shares underlying its convertible notes as they were dilutive for the respective periods.(2) The company adopted the two-class method in calculating net income per share on a GAAP basis, which excludes the weighted average unvested restricted stockawards outstanding of 267,578 and 624,268 for the three months ended January 1, 2011 and January 2, 2010, respectively, and 356,966 and 704,673 for the twelvemonths ended January 1, 2011 and January 2, 2010, respectively.The following table reconciles the specific items excluded from GAAP gross profit and gross margin from continuing operations in the calculation of non-GAAP gross profit and gross margin from continuing operations for the periods shown below:

THORATEC CORPORATIONReconciliation of GAAP to Non-GAAP Gross Profit from Continuing Operations(Unaudited)(in thousands)Three Months Ended Twelve Months Ended January 1, 2011January 2, 2010January 1, 2011January 2, 2010Gross profit
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Presentation at Canaccord Adams Conference to be Webcast
8. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Piper Jaffray Conference to be Webcast
11. Thoratec Presentation at Raymond James Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... -- Stryker Corporation,s Orthopaedics Division, the Official Joint Replacement Products of ... of joint health to golf fans in its home state ... The Barclays.  The company,s fan destination – "The Stryker Mobility ... 17 th fairway at the Ridgewood Country Club in ... st .    At The Barclays, Stryker will ...
(Date:8/19/2014)... N.Y. , Aug. 19, 2014  Regeneron Pharmaceuticals, ... following investor conferences: , Sanofi and Regeneron will host ... Eastern Time on Tuesday, September 2, 2014 , ... on Wednesday, September 3, 2014 , Citi,s 9 ... Time on Thursday, September 4, 2014 , Morgan ...
(Date:8/19/2014)... Luoxis Diagnostics, Inc. , a ... MKT: AMPE), today announced an upcoming presentation at ... American Academy of Surgical Trauma (AAST) and Clinical ... Philadelphia, Pennsylvania that will be held ... from a recently completed five-year prospective clinical trial ...
Breaking Medicine Technology:Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 2Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 3Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 4Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 5Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3
... Oct. 13, 2011 K-V Pharmaceutical Company (the ... of Obstetricians and Gynecologists (ACOG) and Society for ... that ensures healthcare providers, patients, and the payer ... information update emphasizes that previous ACOG and SMFM ...
... 13, 2011 IVD Technology , ... diagnostics technologies including research, development, and manufacturing, today announced ... emerging trend in the industry – ... (CONTACT:   http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ) The featured speaker ...
Cached Medicine Technology:K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 2Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 3
(Date:8/20/2014)... they often have difficulty falling asleep and staying asleep, ... In individuals with Alzheimer,s disease, this common and troubling ... leading to nighttime confusion and wandering. , Now, a ... Center (BIDMC) and the University of Toronto/Sunnybrook Health Sciences ... age. Reported online today in the journal Brain ...
(Date:8/20/2014)... Los Angeles, CA (PRWEB) August 20, 2014 ... will honor the 2014 Emmy Award Nominees and Presenters at ... place on August 22nd and 23rd in Beverly Hills from ... enjoy gifts, refreshments and music by DJ Morgan Hildebrand. , ... charity fundraising and will feature several charities at the lounge. ...
(Date:8/20/2014)... Kowa Optimed returns after a short ... the new SL-17 portable slit lamp. , The SL-17 ... source controlled by an illuminated thumb wheel for easy ... commercially available AAA rechargeable and dry cell batteries, which ... batteries designed specifically for the device. The new Sl-17 ...
(Date:8/20/2014)... York (PRWEB) August 20, 2014 Over 31 ... Global Bureau of Disease, low back pain is the single ... most common reasons for missed work. Americans spend at least ... pain. , Most cases of back pain are not due ... (non-organic) origin. , For example, Pete, a busy accountant, had ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 As moms and ... for themselves to return to the normal routine of dropping ... in tow, Kristen Yarker, MSc, RD encourages them to ... their kids’ snack time. , Yarker explains, “Kids have ... nutrients. Instead of giving them junk food handouts, use snack ...
Breaking Medicine News(10 mins):Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:Physical Therapists Learn to Relieve Low Back Pain 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3
... of stroke victims suffer vision difficulties due to cortical ... holds immense promise for patients suffering partial impairment of ... medical instrument has been devised that is capable of ... This could indeed be the light at the end ...
... gene expression in the mouse brain is considered a scientific ... or 57.7 million people//. , ,The Allen Institute ... The Allen Institute was started in 2003 and the Atlas ... given by Microsoft co-founder Paul G. Allen funded both. ...
... Sufferers,Television personality Angela Rippon is fronting a new DVD ... Chronic Obstructive Pulmonary Disease (COPD). The DVD called Move ... ,COPD includes a range of lung diseases like chronic ... make a difference to the lives of people living ...
... HIV/AIDS is a major hindrance in controlling the fast-spreading disease ... discrimination are indeed problem areas in tackling HIV/AIDS in India," ... for HIV/AIDS in Asia and the Pacific. ,"There ... lots needs to be done to make it (the disease) ...
... for the cartoon man, Popeye, who simply preens at the ... spinach and an icon that little kids swear by, what ... who still boasts of a perfect vision without the help ... with a novel eye device are trying to understand the ...
... Drug Administration takes days to track down the source of ... sensor that can enable growers to do the job themselves ... engineering at Drexel University, has developed an “intelligent” sensor technology ... dollars, the sensor can provide a result within 10 minutes ...
Cached Medicine News:Health News:Allen Brain Atlas – a 3-D gene map of brai 2Health News:Remove Stigma to Defeat HIV/AIDS in India, says UN Envoy 2Health News:Go Green with Popeye: Learn why his eyes pop out for spinach! 2
... Implant System provides todays surgeon with ... head replacement. Modular stem and ... while minimizing ligamentous and soft tissue ... guide assists in both the radial ...
... modular radial head system employs the advantages ... to create the next generation of modular ... part, modular design, the implant system offers ... the patients anatomy. In addition, the capability ...
All Padgett bipolar forceps are foot activated. The standard-type connectors fit generators utilizing the standard receivers for small "banana" inserts. All Padgett bipolar foot activated forceps an...
For connection to the bipolar output of electrosurgical generators....
Medicine Products: